Applied DNA to Announce Second Quarter Fiscal 2025 Financial Results on May 15, Schedules Intra-Quarter Investor Update Call for June 3
Applied DNA Sciences (NASDAQ:APDN) has announced it will release its Q2 FY2025 financial results on May 15, 2025, after U.S. market close. The company will file its Form 10-Q concurrently. Following its Annual Meeting of Stockholders on May 22, Applied DNA will host an intra-quarter investor update call on June 3, 2025, at 4:30 p.m. ET, where management will discuss strategic priorities.
The conference call will be accessible via multiple channels, including domestic (844-887-9402), international (412-317-6798), and Canadian (866-605-3852) dial-in numbers. A webcast replay will be available for 7 days following the call, with access codes provided for different regions.
Applied DNA Sciences (NASDAQ:APDN) ha annunciato che pubblicherà i risultati finanziari del secondo trimestre dell'esercizio 2025 il 15 maggio 2025, dopo la chiusura dei mercati statunitensi. Contestualmente, la società presenterà il modulo 10-Q. Dopo l'Assemblea Annuale degli Azionisti del 22 maggio, Applied DNA terrà una chiamata di aggiornamento per gli investitori a metà trimestre il 3 giugno 2025 alle 16:30 ET, durante la quale la direzione discuterà le priorità strategiche.
La conferenza sarà accessibile tramite diversi canali, inclusi numeri di telefono per chiamate nazionali (844-887-9402), internazionali (412-317-6798) e canadesi (866-605-3852). La registrazione della trasmissione sarà disponibile in streaming per 7 giorni dopo la chiamata, con codici di accesso forniti per le varie regioni.
Applied DNA Sciences (NASDAQ:APDN) ha anunciado que publicará sus resultados financieros del segundo trimestre del año fiscal 2025 el 15 de mayo de 2025, después del cierre del mercado estadounidense. La empresa presentará simultáneamente su Formulario 10-Q. Tras la Junta Anual de Accionistas el 22 de mayo, Applied DNA realizará una llamada de actualización para inversores a mitad de trimestre el 3 de junio de 2025 a las 4:30 p.m. ET, donde la dirección discutirá las prioridades estratégicas.
La conferencia será accesible a través de varios canales, incluyendo números de teléfono nacionales (844-887-9402), internacionales (412-317-6798) y canadienses (866-605-3852). La repetición de la transmisión estará disponible durante 7 días tras la llamada, con códigos de acceso proporcionados para diferentes regiones.
Applied DNA Sciences (NASDAQ:APDN)는 2025년 5월 15일 미국 시장 마감 후 2025 회계연도 2분기 재무 결과를 발표할 예정입니다. 회사는 동시에 Form 10-Q를 제출할 것입니다. 5월 22일 주주 총회 이후, Applied DNA는 2025년 6월 3일 오후 4시 30분(동부 시간)에 분기 중 투자자 업데이트 콜을 개최하여 경영진이 전략적 우선순위에 대해 논의할 예정입니다.
컨퍼런스 콜은 국내(844-887-9402), 국제(412-317-6798), 캐나다(866-605-3852) 전화번호 등 여러 채널을 통해 접속할 수 있습니다. 콜 종료 후 7일간 웹캐스트 재생이 가능하며, 지역별 접근 코드가 제공됩니다.
Applied DNA Sciences (NASDAQ:APDN) a annoncé qu'elle publiera ses résultats financiers du deuxième trimestre de l'exercice 2025 le 15 mai 2025, après la clôture des marchés américains. La société déposera simultanément son formulaire 10-Q. Après l'assemblée annuelle des actionnaires du 22 mai, Applied DNA organisera une conférence téléphonique de mise à jour intermédiaire pour les investisseurs le 3 juin 2025 à 16h30 ET, au cours de laquelle la direction discutera des priorités stratégiques.
La conférence téléphonique sera accessible via plusieurs canaux, incluant des numéros d'appel nationaux (844-887-9402), internationaux (412-317-6798) et canadiens (866-605-3852). Une rediffusion du webcast sera disponible pendant 7 jours après l'appel, avec des codes d'accès fournis pour différentes régions.
Applied DNA Sciences (NASDAQ:APDN) hat angekündigt, dass die Finanzergebnisse für das zweite Quartal des Geschäftsjahres 2025 am 15. Mai 2025 nach US-Marktschluss veröffentlicht werden. Das Unternehmen wird gleichzeitig seinen Formular 10-Q einreichen. Nach der jährlichen Hauptversammlung der Aktionäre am 22. Mai wird Applied DNA am 3. Juni 2025 um 16:30 Uhr ET eine Zwischenquartals-Investorenkonferenz abhalten, bei der das Management die strategischen Prioritäten erläutern wird.
Der Konferenzanruf ist über mehrere Kanäle zugänglich, darunter nationale (844-887-9402), internationale (412-317-6798) und kanadische (866-605-3852) Einwahlnummern. Eine Webcast-Wiedergabe wird für 7 Tage nach dem Anruf verfügbar sein, wobei Zugangscodes für verschiedene Regionen bereitgestellt werden.
- None.
- None.
STONY BROOK, NY / ACCESS Newswire / May 14, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction (PCR)-based technologies, will release its financial results for the second quarter of fiscal year 2025 (ended on March 31, 2025) after the close of the U.S. equity markets on Thursday, May 15, 2025. The Company's Form 10-Q for the period will be filed concurrently and available on the SEC Filings page of its Investor Relations website.
To align with its Annual Meeting of Stockholders on May 22 and ensure a comprehensive post-meeting update, the Company will hold an intra-quarter investor update call on June 3, on which management will discuss the Company's strategic priorities.
Webcast and Conference Call Date & Time: Tuesday, June 3 @ 4:30 p.m. Eastern Time
Dial In:
Domestic callers (toll free): 844-887-9402
International callers: 412-317-6798
Canadian callers (toll free): 866-605-3852
Live webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=Ky09znsL
A replay of the conference call will be available for 7 days following the conclusion of the call:
Replay for domestic callers (toll free): 877-344-7529, replay access code 3446494
Replay for international callers: 412-317-0088, replay access code 3446494
Replay for Canadian callers (toll free): 855-669-9658, replay access code 3446494
An accompanying slide presentation will be embedded in the webcast (live and replay) that will also be accessible as a stand-alone document via the 'Company Presentations' page of the Applied DNA investor relations website. The webcast replay of the call will be available approximately one hour after the end of the call on the 'Company Events' page.
About Applied DNA Sciences
Applied DNA Sciences is a biotechnology company developing technologies to produce and detect deoxyribonucleic acid ("DNA"). Using the polymerase chain reaction ("PCR") to enable both the production and detection of DNA, we operate in two business markets: (i) the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and the development and sale of a proprietary RNA polymerase ("RNAP") for use in the production of mRNA therapeutics; and (ii) the detection of DNA and RNA in molecular diagnostics and genetic testing services.
Visit adnas.com for more information. Follow us on X and LinkedIn. Join our mailing list.
For additional information:
Investor Relations: Sanjay M. Hurry, 917-733-5573, sanjay.hurry@adnas.com
Web: https://investors.adnas.com/
###
SOURCE: Applied DNA Sciences
View the original press release on ACCESS Newswire
FAQ
When will Applied DNA (APDN) release its Q2 2025 earnings?
When is Applied DNA's (APDN) investor update call scheduled for Q2 2025?
How can I access Applied DNA's (APDN) Q2 2025 earnings call?
How long will the replay of Applied DNA's Q2 2025 earnings call be available?
